Bioventus (BVS) EBT Margin (QoQ) (2020 - 2026)
Bioventus (BVS) EBT Margin (QoQ) (2020 - 2026) Analysis & Trends
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Abbott Laboratories | 200.19 Bn | 194.59 Bn | 7.27 Bn |
| 2 | Stryker | 129.95 Bn | 126.47 Bn | 4.50 Bn |
| 3 | Medtronic | 120.06 Bn | 110.84 Bn | 6.41 Bn |
| 4 | Boston Scientific | 74.14 Bn | 73.60 Bn | 3.85 Bn |
| 5 | Edwards Lifesciences | 52.74 Bn | 48.49 Bn | 1.35 Bn |
| 6 | Dexcom | 34.60 Bn | 32.65 Bn | 830.00 Mn |
| 7 | GE HealthCare Technologies | 34.20 Bn | 32.10 Bn | 2.18 Bn |
| 8 | Koninklijke Philips | 26.46 Bn | 23.13 Bn | 4.55 Bn |
| 9 | Steris | 23.25 Bn | 22.77 Bn | 684.20 Mn |
| 10 | Bioventus | 974.94 Mn | 945.48 Mn | 105.67 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 27, 2026 | 657.00 |
| Mar 28, 2026 | -554.00 |
| Dec 31, 2025 | 559.00 |
| Sep 27, 2025 | -362.00 |
| Jun 28, 2025 | 974.00 |
| Mar 29, 2025 | -272.00 |
| Dec 31, 2024 | 375.00 |
| Sep 28, 2024 | 2,370.00 |
| Jun 29, 2024 | -2,325.00 |
| Mar 30, 2024 | 198.00 |
| Dec 31, 2023 | 57.00 |
| Sep 30, 2023 | -361.00 |
| Jul 1, 2023 | 8,096.00 |
| Apr 1, 2023 | -5,835.00 |
| Dec 31, 2022 | 7,569.00 |
| Oct 1, 2022 | -9,685.00 |
| Jul 2, 2022 | 1,203.00 |
| Apr 2, 2022 | -1,455.00 |
| Dec 31, 2021 | 79.00 |
| Oct 2, 2021 | 536.00 |